BANCHI, MARTA Statistiche
BANCHI, MARTA
DIPARTIMENTO DI RICERCA TRASLAZIONALE E DELLE NUOVE TECNOLOGIE IN MEDICINA E CHIRURGIA
Complete remission of a diffuse large B-cell lymphoma in a young patient, with severe tuberous sclerosis, treated with metronomic chemotherapy and ibrutinib: a case report
2024-01-01 Banchi, Marta; Lanzolla, Tiziana; Di Napoli, Arianna; Bandini, Arianna; Bocci, Guido; Cox, Maria Christina
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib
2024-01-01 Orlandi, Paola; Banchi, Marta; Vaglini, Francesca; Carli, Marco; Aringhieri, Stefano; Bandini, Arianna; Pardini, Carla; Viaggi, Cristina; Lai, Michele; Alì, Greta; Ottani, Alessandra; Vandini, Eleonora; Guidi, Patrizia; Bernardeschi, Margherita; La Rocca, Veronica; Francia, Giulio; Fontanini, Gabriella; Pistello, Mauro; Frenzilli, Giada; Giuliani, Daniela; Scarselli, Marco; Bocci, Guido
Metronomic Chemotherapy in Elderly Patients
2024-01-01 Bandini, Arianna; Calabrò, Pasquale Fabio; Banchi, Marta; Orlandi, Paola; Bocci, Guido
Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules
2024-01-01 Banchi, M.; Cox, M. C.; Bocci, G.
Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase
2023-01-01 Tinivella, Annachiara; Banchi, Marta; Gambacorta, Guido; Borghi, Federica; Orlandi, Paola; Baxendale, Ian R; Di Paolo, Antonello; Bocci, Guido; Pinzi, Luca; Rastelli, Giulio
A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients
2022-01-01 Coltelli, L.; Allegrini, G.; Orlandi, P.; Finale, C.; Fontana, A.; Masini, L. C.; Scalese, M.; Arrighi, G.; Barletta, M. T.; De Maio, E.; Banchi, M.; Fini, E.; Guidi, P.; Frenzilli, G.; Donati, S.; Giovannelli, S.; Tanganelli, L.; Salvadori, B.; Livi, L.; Meattini, I.; Pazzagli, I.; Di Lieto, M.; Pistelli, M.; Casadei, V.; Ferro, A.; Cupini, S.; Orlandi, F.; Francesca, D.; Lorenzini, G.; Barellini, L.; Falcone, A.; Cosimi, A.; Bocci, G.
Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer
2022-01-01 Fornaro, L.; Musettini, G.; Orlandi, P.; Pecora, I.; Vivaldi, C.; Banchi, M.; Salani, F.; Fini, E.; Massa, V.; Catanese, S.; Cucchiara, F.; Lencioni, M.; Masi, G.; Vasile, E.; Bocci, G.
Metronomic chemotherapy and antiangiogenic drugs: Preclinical and clinical data
2022-01-01 Bocci, Guido; Banchi, Marta; Garcia, Diana Gonzalez; Batson, Serina; Francia, Giulio
Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies
2022-01-01 Banchi, Marta; Fini, Elisabetta; Crucitta, Stefania; Bocci, Guido
Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma
2022-01-01 Bocci, Guido; Pelliccia, Sabrina; Orlandi, Paola; Caridi, Matteo; Banchi, Marta; Musuraca, Gerardo; Di Napoli, Arianna; Bianchi, Maria Paola; Patti, Caterina; Anticoli-Borza, Paola; Battistini, Roberta; Casaroli, Ivana; Lanzolla, Tiziana; Tafuri, Agostino; Cox, Maria Christina
Antiangiogenic drugs in NASH: Evidence of a possible new therapeutic approach
2021-01-01 Orlandi, P.; Solini, A.; Banchi, M.; Brunetto, M. R.; Cioni, D.; Ghiadoni, L.; Bocci, G.
Active metronomic vinorelbine schedules decrease plasma interleukin-2 levels in mice with Lewis lung carcinoma
2020-01-01 Orlandi, Paola; Banchi, Marta; Alì, Greta; Di Desidero, Teresa; Fini, Elisabetta; Fontanini, Gabriella; Bocci, Guido
All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma
2020-01-01 Cox, M. C.; Banchi, M.; Pelliccia, S.; Di Napoli, A.; Marcheselli, L.; Patti, C.; Anticoli Borza, P.; Battistini, R.; Di Gregorio, F.; Orlandi, P.; Bocci, G.
Pharmacological effects of the simultaneous and sequential combinations of trifluridine/tipiracil (TAS-102) and 5-fluorouracil in fluoropyrimidine-sensitive colon cancer cells
2020-01-01 Orlandi, P.; Gentile, D.; Banchi, M.; Cucchiara, F.; Di Desidero, T.; Cremolini, C.; Moretto, R.; Falcone, A.; Bocci, G.
Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer
2020-01-01 Di Desidero, T.; Orlandi, P.; Gentile, D.; Banchi, M.; Ali, G.; Kusmic, C.; Armanetti, P.; Cayme, G. J.; Menichetti, L.; Fontanini, G.; Francia, G.; Bocci, G.
Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer
2020-01-01 Gentile, D.; Orlandi, P.; Banchi, M.; Bocci, G.
Synergistic activity of linifanib and irinotecan increases the survival of mice bearing orthotopically implanted human anaplastic thyroid cancer
2020-01-01 Banchi, Marta; Orlandi, Paola; Gentile, Daniela; Alì, Greta; Fini, Elisabetta; Fontanini, Gabriella; Francia, Giulio; Bocci, Guido
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Complete remission of a diffuse large B-cell lymphoma in a young patient, with severe tuberous sclerosis, treated with metronomic chemotherapy and ibrutinib: a case report | 1-gen-2024 | Banchi, Marta; Lanzolla, Tiziana; Di Napoli, Arianna; Bandini, Arianna; Bocci, Guido; Cox, Maria Christina | |
| Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib | 1-gen-2024 | Orlandi, Paola; Banchi, Marta; Vaglini, Francesca; Carli, Marco; Aringhieri, Stefano; Bandini, Arianna; Pardini, Carla; Viaggi, Cristina; Lai, Michele; Alì, Greta; Ottani, Alessandra; Vandini, Eleonora; Guidi, Patrizia; Bernardeschi, Margherita; La Rocca, Veronica; Francia, Giulio; Fontanini, Gabriella; Pistello, Mauro; Frenzilli, Giada; Giuliani, Daniela; Scarselli, Marco; Bocci, Guido | |
| Metronomic Chemotherapy in Elderly Patients | 1-gen-2024 | Bandini, Arianna; Calabrò, Pasquale Fabio; Banchi, Marta; Orlandi, Paola; Bocci, Guido | |
| Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules | 1-gen-2024 | Banchi, M.; Cox, M. C.; Bocci, G. | |
| Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase | 1-gen-2023 | Tinivella, Annachiara; Banchi, Marta; Gambacorta, Guido; Borghi, Federica; Orlandi, Paola; Baxendale, Ian R; Di Paolo, Antonello; Bocci, Guido; Pinzi, Luca; Rastelli, Giulio | |
| A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients | 1-gen-2022 | Coltelli, L.; Allegrini, G.; Orlandi, P.; Finale, C.; Fontana, A.; Masini, L. C.; Scalese, M.; Arrighi, G.; Barletta, M. T.; De Maio, E.; Banchi, M.; Fini, E.; Guidi, P.; Frenzilli, G.; Donati, S.; Giovannelli, S.; Tanganelli, L.; Salvadori, B.; Livi, L.; Meattini, I.; Pazzagli, I.; Di Lieto, M.; Pistelli, M.; Casadei, V.; Ferro, A.; Cupini, S.; Orlandi, F.; Francesca, D.; Lorenzini, G.; Barellini, L.; Falcone, A.; Cosimi, A.; Bocci, G. | |
| Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer | 1-gen-2022 | Fornaro, L.; Musettini, G.; Orlandi, P.; Pecora, I.; Vivaldi, C.; Banchi, M.; Salani, F.; Fini, E.; Massa, V.; Catanese, S.; Cucchiara, F.; Lencioni, M.; Masi, G.; Vasile, E.; Bocci, G. | |
| Metronomic chemotherapy and antiangiogenic drugs: Preclinical and clinical data | 1-gen-2022 | Bocci, Guido; Banchi, Marta; Garcia, Diana Gonzalez; Batson, Serina; Francia, Giulio | |
| Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies | 1-gen-2022 | Banchi, Marta; Fini, Elisabetta; Crucitta, Stefania; Bocci, Guido | |
| Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma | 1-gen-2022 | Bocci, Guido; Pelliccia, Sabrina; Orlandi, Paola; Caridi, Matteo; Banchi, Marta; Musuraca, Gerardo; Di Napoli, Arianna; Bianchi, Maria Paola; Patti, Caterina; Anticoli-Borza, Paola; Battistini, Roberta; Casaroli, Ivana; Lanzolla, Tiziana; Tafuri, Agostino; Cox, Maria Christina | |
| Antiangiogenic drugs in NASH: Evidence of a possible new therapeutic approach | 1-gen-2021 | Orlandi, P.; Solini, A.; Banchi, M.; Brunetto, M. R.; Cioni, D.; Ghiadoni, L.; Bocci, G. | |
| Active metronomic vinorelbine schedules decrease plasma interleukin-2 levels in mice with Lewis lung carcinoma | 1-gen-2020 | Orlandi, Paola; Banchi, Marta; Alì, Greta; Di Desidero, Teresa; Fini, Elisabetta; Fontanini, Gabriella; Bocci, Guido | |
| All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma | 1-gen-2020 | Cox, M. C.; Banchi, M.; Pelliccia, S.; Di Napoli, A.; Marcheselli, L.; Patti, C.; Anticoli Borza, P.; Battistini, R.; Di Gregorio, F.; Orlandi, P.; Bocci, G. | |
| Pharmacological effects of the simultaneous and sequential combinations of trifluridine/tipiracil (TAS-102) and 5-fluorouracil in fluoropyrimidine-sensitive colon cancer cells | 1-gen-2020 | Orlandi, P.; Gentile, D.; Banchi, M.; Cucchiara, F.; Di Desidero, T.; Cremolini, C.; Moretto, R.; Falcone, A.; Bocci, G. | |
| Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer | 1-gen-2020 | Di Desidero, T.; Orlandi, P.; Gentile, D.; Banchi, M.; Ali, G.; Kusmic, C.; Armanetti, P.; Cayme, G. J.; Menichetti, L.; Fontanini, G.; Francia, G.; Bocci, G. | |
| Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancer | 1-gen-2020 | Gentile, D.; Orlandi, P.; Banchi, M.; Bocci, G. | |
| Synergistic activity of linifanib and irinotecan increases the survival of mice bearing orthotopically implanted human anaplastic thyroid cancer | 1-gen-2020 | Banchi, Marta; Orlandi, Paola; Gentile, Daniela; Alì, Greta; Fini, Elisabetta; Fontanini, Gabriella; Francia, Giulio; Bocci, Guido |